These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7098379

  • 21. Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs.
    Seth V, Beotra A.
    Indian J Med Res; 1989 Sep; 89():306-9. PubMed ID: 2628292
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
    Pregowski W, Stanczuk A, Znaniecka H, Cesarz-Fronczyk M.
    Z Erkr Atmungsorgane; 1976 May; 145(2):220-6. PubMed ID: 983179
    [Abstract] [Full Text] [Related]

  • 25. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 26. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
    Neill P, Pringle D, Mhonda M, Kusema T, Nhachi CF.
    Cent Afr J Med; 1990 Apr; 36(4):104-7. PubMed ID: 2225025
    [Abstract] [Full Text] [Related]

  • 27. [Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
    Musch E, Eichelbaum M, Wang JK, von Sassen W, Ochs HR, Castro-Parra M, Dengler HJ.
    Med Welt; 1982 Jun 25; 33(25):911-4. PubMed ID: 7109939
    [No Abstract] [Full Text] [Related]

  • 28. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O, Uhari M.
    Eur J Pediatr; 1980 Sep 25; 134(3):227-9. PubMed ID: 6968680
    [Abstract] [Full Text] [Related]

  • 29. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
    Teixeira RL, Morato RG, Cabello PH, Muniz LM, Moreira Ada S, Kritski AL, Mello FC, Suffys PN, Miranda AB, Santos AR.
    Mem Inst Oswaldo Cruz; 2011 Sep 25; 106(6):716-24. PubMed ID: 22012226
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K, Oizumi K, Yamada S, Ogata K, Sato M.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep 25; 19(2):68-72. PubMed ID: 4649624
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
    Albengres E, Houin G, Breau JL, Hirsch A, Saltiel JC, Tillement JP, Chrétien J.
    Nouv Presse Med; 1977 Oct 01; 6(32):2869-71. PubMed ID: 917803
    [Abstract] [Full Text] [Related]

  • 34. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY, Meyniel D, Petit J, Gustot P, Darnis F.
    Ann Med Interne (Paris); 1979 Oct 01; 130(6-7):371-5. PubMed ID: 496138
    [Abstract] [Full Text] [Related]

  • 35. [Isoniazid induced neuropathy: consider prevention].
    Steichen O, Martinez-Almoyna L, De Broucker T.
    Rev Mal Respir; 2006 Apr 01; 23(2 Pt 1):157-60. PubMed ID: 16788441
    [Abstract] [Full Text] [Related]

  • 36. [Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
    Fiala W, Häcki MA, Brändli O.
    Schweiz Med Wochenschr; 1983 Dec 24; 113(51):1956-9. PubMed ID: 6658432
    [Abstract] [Full Text] [Related]

  • 37. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y, Nagayama N, Kawabe Y, Shimada M, Suzuki J, Kunogi M, Matsui Y, Kawashima M, Suzuki J, Ariga H, Oshima N, Masuda K, Matsui H, Nagai H, Tamura A, Akagawa S, Toyoda E, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2008 Jan 24; 83(1):13-9. PubMed ID: 18283910
    [Abstract] [Full Text] [Related]

  • 38. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
    Farmakis M, Travlou O, Aroni S, Fertakis A.
    Arzneimittelforschung; 1992 Aug 24; 42(8):1041-4. PubMed ID: 1418078
    [Abstract] [Full Text] [Related]

  • 39. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P, Kindler U, Austerhoff A.
    Dtsch Med Wochenschr; 1977 Dec 30; 102(52):1913-5. PubMed ID: 598300
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.